Nuveen Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-143,473
| Closed | -$475K | – | 3434 |
|
|
2022
Q1 | $475K | Buy |
143,473
+1,544
| +1% | +$5.11K | ﹤0.01% | 3032 |
|
|
2021
Q4 | $479K | Sell |
141,929
-9,529
| -6% | -$32.2K | ﹤0.01% | 3082 |
|
|
2021
Q3 | $1.32M | Buy |
151,458
+3,724
| +3% | +$32.5K | ﹤0.01% | 2867 |
|
|
2021
Q2 | $1.68M | Buy |
+147,734
| New | +$1.68M | ﹤0.01% | 2790 |
|